Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 278

1.

Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice.

Pushko P, Tumpey TM, Bu F, Knell J, Robinson R, Smith G.

Vaccine. 2005 Dec 30;23(50):5751-9. Epub 2005 Aug 15.

PMID:
16143432
2.

Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.

Bright RA, Carter DM, Daniluk S, Toapanta FR, Ahmad A, Gavrilov V, Massare M, Pushko P, Mytle N, Rowe T, Smith G, Ross TM.

Vaccine. 2007 May 10;25(19):3871-8. Epub 2007 Feb 15.

PMID:
17337102
3.

Evaluation of influenza virus-like particles and Novasome adjuvant as candidate vaccine for avian influenza.

Pushko P, Tumpey TM, Van Hoeven N, Belser JA, Robinson R, Nathan M, Smith G, Wright DC, Bright RA.

Vaccine. 2007 May 22;25(21):4283-90. Epub 2007 Mar 9.

PMID:
17403562
4.

Protection against avian influenza H9N2 virus challenge by immunization with hemagglutinin- or neuraminidase-expressing DNA in BALB/c mice.

Qiu M, Fang F, Chen Y, Wang H, Chen Q, Chang H, Wang F, Wang H, Zhang R, Chen Z.

Biochem Biophys Res Commun. 2006 May 19;343(4):1124-31. Epub 2006 Mar 23.

PMID:
16580631
5.

A cell culture-derived whole-virus H9N2 vaccine induces high titer antibodies against hemagglutinin and neuraminidase and protects mice from severe lung pathology and weight loss after challenge with a highly virulent H9N2 isolate.

Wodal W, Falkner FG, Kerschbaum A, Gaiswinkler C, Fritz R, Kiermayr S, Portsmouth D, Savidis-Dacho H, Coulibaly S, Piskernik C, Hohenadl C, Howard MK, Kistner O, Barrett PN, Kreil TR.

Vaccine. 2012 Jun 29;30(31):4625-31. doi: 10.1016/j.vaccine.2012.04.102. Epub 2012 May 10.

PMID:
22580355
6.

Recombinant H1N1 virus-like particle vaccine elicits protective immunity in ferrets against the 2009 pandemic H1N1 influenza virus.

Pushko P, Kort T, Nathan M, Pearce MB, Smith G, Tumpey TM.

Vaccine. 2010 Jul 5;28(30):4771-6. doi: 10.1016/j.vaccine.2010.04.093. Epub 2010 May 12.

PMID:
20470801
7.

Generation and evaluation of an H9N1 influenza vaccine derived by reverse genetics that allows utilization of a DIVA strategy for control of H9N2 avian influenza.

Wu R, Chen Q, Zheng L, Chen J, Sui Z, Guan Y, Chen Z.

Arch Virol. 2009;154(8):1203-10. doi: 10.1007/s00705-009-0425-6. Epub 2009 Jun 19.

PMID:
19543688
8.

Intranasal vaccination with H5, H7 and H9 hemagglutinins co-localized in a virus-like particle protects ferrets from multiple avian influenza viruses.

Tretyakova I, Pearce MB, Florese R, Tumpey TM, Pushko P.

Virology. 2013 Jul 20;442(1):67-73. doi: 10.1016/j.virol.2013.03.027. Epub 2013 Apr 22.

9.

H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses.

Mahmood K, Bright RA, Mytle N, Carter DM, Crevar CJ, Achenbach JE, Heaton PM, Tumpey TM, Ross TM.

Vaccine. 2008 Oct 3;26(42):5393-9. doi: 10.1016/j.vaccine.2008.07.084. Epub 2008 Aug 14.

PMID:
18706956
10.
12.

Influenza-pseudotyped Gag virus-like particle vaccines provide broad protection against highly pathogenic avian influenza challenge.

Haynes JR, Dokken L, Wiley JA, Cawthon AG, Bigger J, Harmsen AG, Richardson C.

Vaccine. 2009 Jan 22;27(4):530-41. doi: 10.1016/j.vaccine.2008.11.011. Epub 2008 Nov 19.

PMID:
19026705
14.
16.

A live bivalent influenza vaccine based on a H9N2 virus strain.

Wu R, Guan Y, Yang Z, Chen J, Wang H, Chen Q, Sui Z, Fang F, Chen Z.

Vaccine. 2010 Jan 8;28(3):673-80. doi: 10.1016/j.vaccine.2009.10.102. Epub 2009 Nov 3.

PMID:
19892041
18.

Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses.

Du N, Li W, Li Y, Liu S, Sui Y, Qu Z, Wang Y, Du Y, Xu B.

Vaccine. 2008 Jun 2;26(23):2912-8. doi: 10.1016/j.vaccine.2008.03.048. Epub 2008 Apr 11.

PMID:
18448208
19.
20.

Production and characterization of mammalian virus-like particles from modified vaccinia virus Ankara vectors expressing influenza H5N1 hemagglutinin and neuraminidase.

Schmeisser F, Adamo JE, Blumberg B, Friedman R, Muller J, Soto J, Weir JP.

Vaccine. 2012 May 14;30(23):3413-22. doi: 10.1016/j.vaccine.2012.03.033. Epub 2012 Mar 29.

PMID:
22465746

Supplemental Content

Support Center